When it Comes to Crohn's, a Fecal Transplant Can Save Lives
The procedure is not yet FDA-approved, but it is still allowed since it's in experimental stages
The research field is advancing and evidence is growing, suggesting that FMT has the potential to treat diseases beyond C. diff, including inflammatory diseases such as Crohn’s disease and ulcerative colitis. However, the FDA continues to face challenges balancing public health, safety of the treatment, as well as economic impact. While the agency has not approved FMT as standard treatment for any infection or disease, they do, however, allow healthcare professionals to conduct the procedure if they inform the patient that the procedure is in the experimental stages, if they get the patient’s informed consent, and if they inform the patient of the risks involved.
